Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. - Wikidata - awgldk - TriplyDB

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

http://www.wikidata.org/entity/Q53491085

about

Non-surgical versus surgical treatment for oesophageal cancer Surgical versus non-surgical treatment for oesophageal cancer Feeding Challenges in Patients with Esophageal and Gastroesophageal Cancers Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer Perioperative and Palliative Chemotherapy for Esophageal Cancer Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and Survival Surgical indications and optimization of patients for resectable esophageal malignancies Radiation therapy and esophageal cancer The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice Advances in Radiotherapy Management of Esophageal Cancer Neoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatment Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after neoadjuvant chemoradiotherapy: a meta-analysis.A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma.Tumor heterogeneity: causes and consequences High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.Radio(chemo)therapy in Elderly Patients with Esophageal Cancer: A Feasible Treatment with an Outcome Consistent with Younger Patients.Current management of esophageal cancer Esophageal cancer: staging system and guidelines for staging and treatment.Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.Current strategies in chemoradiation for esophageal cancer.Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study.Esophageal cancer management controversies: Radiation oncology point of view Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma.Comparison Between Concurrent Chemoradiation Followed by Surgery vs. Surgery for Locally Advanced Cancer of Esophagus A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer.Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy

P2860

Q24186005-4236447D-60C8-48AF-AF40-30A334FEC796 Q24186841-7A2F1080-8181-446E-A439-8A7D6B7D1C1C Q26741107-4591EC11-C9D0-4C55-A2F7-9B0F8F7D0905 Q26753864-D779C514-D42E-465C-A957-E4EBADE24FF3 Q26753865-DBAEFBAC-1886-4E00-849C-DD7B2874BCEA Q26777898-862B2789-F89E-4F7F-AC13-8D014439FA42 Q26798220-DEE085C6-FB28-40E7-B4A1-8837A78FC2F8 Q26861000-6AA3FEC9-B8AC-41E3-9785-E1C9B1BB0546 Q27026922-D29BDFB3-118A-46A4-948E-0DA786D63AAC Q27687612-99665017-3BDB-4652-B7AA-80BB4D16A541 Q28073933-A057F1A0-E416-4555-88ED-F3FED85F5601 Q28078750-57E1104A-D04E-4E0A-97F5-BA47EFCFEF70 Q28086781-9477D823-776F-42B5-983E-C44B2A364344 Q30244382-7AC1CCF2-1BEB-4DE2-9801-DE9A6C787840 Q30252101-62FC46FF-2F96-4EFE-B42A-E56D05519DB5 Q30393722-4D4B3778-89AB-4F8E-8232-C27D80BAF839 Q33439909-857F345F-5A95-4582-ACC7-7D4D06BA39E9 Q33624298-161200BE-960F-4BCB-8933-7F1C1024E6A9 Q33633596-0E2EF791-4DE2-4074-B411-20DF9EB5B52A Q33633972-C791F44E-2C12-468D-8743-8B0B1EA7C7B6 Q33658207-2D25E668-7C22-41E6-B4D3-00A3674AC6F0 Q33680811-C620F008-5F67-45BC-8FBF-512FECEC63A2 Q33702692-434C3DA0-43C6-418B-86F9-06EA343E82ED Q33779432-2025E866-53CF-4469-A32C-7896D38467F2 Q33798433-6FAD0282-48BD-4F6D-A315-8315C4FD6EBB Q33820782-DEC8942B-5523-4F4D-8CBB-7E5519879370 Q33891544-C258F59C-374C-4595-9E25-15A4F2AD1D6D Q33918140-51C6FDEE-E02A-4035-97B5-A93346A7DD89 Q33933542-5B5D765C-7E72-49BB-95C6-557BAB3E87D0 Q34049113-20A44A66-D8E4-41A7-8FDC-CD2453092D26 Q34204650-F86B2090-A88D-474F-9321-B49875CB7A12 Q34231941-A03C5EAE-DA63-4701-87DD-FDE2D6E0D888 Q34374229-ECD4A647-AFBB-4498-971F-FE7A54AF0A82 Q34382399-2D897FFB-2734-4A31-BEF8-60CECD1B4745 Q34488764-56AE947B-3916-4EF1-BFB8-0FE82F14E117 Q34753345-2D704AB0-5E44-4F49-ADD2-CA69438AD268 Q34796876-CD25DF40-6263-49BE-9B97-C916A776222C Q34961992-9E92B390-6E78-4A35-BFC7-DE8399D7276E Q34980099-18053651-353A-4088-9F63-7C12F3A1FF1A Q35129311-21870B03-496F-4278-BDC9-3D686F4A103B

P2860

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

http://www.wikidata.org/entity/Q53491085

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.

@en

Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.

@nl

type

label

Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.

@en

Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.

@nl

prefLabel

Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.

@en

Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.

@nl

P1433

Q53491085-123FE2D9-6E45-4BAE-8ABD-609D5350C54C

P1476

Q53491085-E74F5FD2-B2A3-46AB-ACB2-F77F9CF2F5EE

P2093

Q53491085-268D4325-A817-4690-A1B4-374419D58FDB

Q53491085-29A605F7-F103-4C42-9A1F-26DB407F3B0F

Q53491085-3485F62F-21F0-4490-B635-219BE0E00149

Q53491085-3A8CEFBB-FD32-4727-87BB-AED5CB2EBCD2

Q53491085-52B880FF-8364-4EE4-9F21-35F3E2F483E0

Q53491085-87BCA762-5671-4694-86C3-C2035E0368FA

Q53491085-99131831-3C29-4F25-9979-9BD53734175D

Q53491085-AA5DB2BD-675F-4191-B47D-0D70BB6B8333

Q53491085-ABD1C629-AC37-4DD9-B2B3-823DC71A97C4

Q53491085-AC053B2C-7E6B-4734-8F8A-4ACE42205EA1

P304

Q53491085-79D25505-44CA-4E2D-952E-09C5CCCAA522

P31

Q53491085-9FCE8FCC-6600-4E7B-8ACB-0C4B5815BE20

P356

Q53491085-D432B763-0061-40B9-82D7-211E9F7C7647

P407

Q53491085-CA715D4A-4191-4300-9D17-E00CC2B3C102

P433

Q53491085-9D8A0716-49B0-4C91-B714-4B521FEA9D25

P478

Q53491085-D45D0D9C-4D00-478F-9A58-70C5324981AF

P50

Q53491085-A3D29E98-1A89-45D7-A5D7-AB8564CCF2EF

P577

Q53491085-2A9FE72C-EB56-41DA-AE72-0B4621B34AE4

P698

Q53491085-9C036795-F5EF-4A0C-9F73-5A14464A2F48

P921

Q53491085-C1A5AA40-8880-4142-8C78-95F53A80FB48

P356

JCO.2005.04.7118

P1433

Journal of Clinical Oncology

P1476

Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.

@en

P2093

Bernard Paillot

http://www.w3.org/2001/XMLSchema#string

Bernard Roullet

http://www.w3.org/2001/XMLSchema#string

Chantal Milan

http://www.w3.org/2001/XMLSchema#string

Christine Binquet

http://www.w3.org/2001/XMLSchema#string

Christophe Mariette

http://www.w3.org/2001/XMLSchema#string

Denis Pezet

http://www.w3.org/2001/XMLSchema#string

Franck Bonnetain

http://www.w3.org/2001/XMLSchema#string

Jean-François Seitz

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Herr

http://www.w3.org/2001/XMLSchema#string

Laurent Bedenne

http://www.w3.org/2001/XMLSchema#string

P304

1160-1168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.04.7118

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17401004

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy